StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
39
This month
1
This year
6
Publishing Date
2024 - 04 - 11
1
2024 - 03 - 25
1
2024 - 03 - 19
1
2024 - 02 - 08
1
2024 - 01 - 08
2
2023 - 11 - 07
1
2023 - 10 - 31
1
2023 - 10 - 12
1
2023 - 07 - 27
1
2023 - 07 - 04
1
2023 - 05 - 18
1
2023 - 03 - 02
1
2023 - 02 - 03
1
2022 - 12 - 06
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 03
1
2022 - 10 - 27
1
2022 - 10 - 19
1
2022 - 10 - 18
1
2022 - 10 - 14
1
2022 - 08 - 22
1
2022 - 08 - 12
1
2022 - 08 - 04
1
2022 - 07 - 25
1
2022 - 06 - 24
1
2022 - 06 - 17
1
2022 - 06 - 03
1
2022 - 05 - 18
1
2022 - 05 - 16
1
2022 - 05 - 05
1
2022 - 05 - 03
1
2021 - 10 - 22
1
2021 - 10 - 04
1
2021 - 08 - 05
1
2021 - 08 - 02
1
2021 - 07 - 28
1
2021 - 05 - 06
1
Sector
Health services
2
Health technology
39
Manufacturing
1
N/a
3
Producer manufacturing
1
Tags
Acquire
1
Agreement
1
Alliances
3
America
1
Anemia
1
Application
1
Approval
1
Approved
3
Astrazeneca
2
Bioscience
1
Biosimilar
1
Breast cancer
1
Business
1
Cancer
8
Ce mark
1
Ceo
1
Children
1
Clinical-trials-phase-ii
1
Companies
1
Designation
1
Device
1
Drug
2
Drug delivery
1
Earnings
2
Enhertu
4
Eplontersen
1
Fda
2
Fda approval
1
Fda-approvals
1
Fibrosis
1
Financial
1
Financial results
1
First
1
For
1
Fpi-2068
1
Genetown
3
Global
5
Granted
2
Growing
1
Growth
3
Her2
3
Her2-
3
Hypertension
1
Ik-930
1
Immunotherapy
1
Influenza
1
Insulin
1
Key
1
Market
13
Metastatic breast cancer
2
N/a
23
People
2
Regulatory
2
Report
5
Research
7
Results
7
Therapy
3
Treatment
2
Trial
2
Update
2
Entities
3m company
54
Abb ltd
65
Abbott laboratories
77
Abbvie inc.
58
Agnico eagle mines limited
63
Apple inc.
57
Arrival
210
Barrick gold corporation
50
Becton, dickinson and company
80
Beigene, ltd.
50
Bio-key international, inc.
63
Bio-techne corp
50
Biogen inc.
47
Bridgebio pharma, inc.
60
Bristol-myers squibb company
108
Canadian solar inc.
68
Castle biosciences, inc.
67
Centene corporation
49
Danaher corporation
48
Draganfly inc
64
Eli lilly and company
173
Ericsson
82
Ford motor company
57
Fti consulting, inc.
108
General electric company
66
Glaxosmithkline plc
74
Honeywell international inc.
93
Hubspot, inc.
458
Intel corporation
50
International business machines corporation
48
Ionis pharmaceuticals, inc.
48
Jacobs engineering group inc.
52
Johnson & johnson
351
Kering
68
Lithium corp
121
Lockheed martin corporation
50
Medtronic plc
71
Merck & company, inc.
121
Microsoft corporation
85
Moderna, inc.
61
Morgan stanley
385
Nextera energy, inc.
47
Novartis ag
83
Novo nordisk a/s
65
Oracle corporation
119
Orange
472
Parsons corporation
58
Pfizer, inc.
90
Posco
51
Precision biosciences, inc.
47
Regeneron pharmaceuticals, inc.
50
Sanofi
344
Sap se
80
Teleflex incorporated
56
Thermo fisher scientific inc
75
Tilray, inc.
48
Transunion
83
Verizon communications inc.
57
Wimi hologram cloud inc.
63
X financial
47
Symbols
ABBV
2
ABT
2
ADAP
1
AMGN
4
ARTL
1
ARWR
1
AVTX
1
AZN
39
AZNCF
23
BAX
2
BGNE
1
BIIB
1
BMY
1
BNTX
1
BPMC
1
BSX
1
CGEN
2
CMXHF
2
CRNX
1
CSLLY
2
ENTX
1
FGEN
1
FUSN
2
GILD
1
GLAXF
8
GLPG
1
GLPGF
1
GNLX
1
GSK
8
HCM
1
HLN
1
HLNCF
1
IONS
2
JNJ
3
LLY
5
MDT
1
MEDE
1
MMM
1
MRNA
1
MTLHF
1
MTLHY
1
NEO
1
NVO
2
NVS
7
NVSEF
6
NVTA
1
PFE
2
PHG
1
PODD
1
QURE
1
RVP
1
SNY
7
SNYNF
7
TEVJF
2
TMO
1
UTHR
1
Exchanges
Amex
1
Nasdaq
39
Nyse
19
Crawled Date
2024 - 04 - 11
1
2024 - 03 - 25
1
2024 - 03 - 19
1
2024 - 02 - 08
1
2024 - 01 - 08
2
2023 - 11 - 07
1
2023 - 10 - 31
1
2023 - 10 - 12
1
2023 - 07 - 27
1
2023 - 07 - 04
1
2023 - 05 - 18
1
2023 - 03 - 02
1
2023 - 02 - 03
1
2022 - 12 - 06
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 03
1
2022 - 10 - 27
1
2022 - 10 - 19
1
2022 - 10 - 18
1
2022 - 10 - 14
1
2022 - 08 - 22
1
2022 - 08 - 12
1
2022 - 08 - 04
1
2022 - 07 - 25
1
2022 - 06 - 24
1
2022 - 06 - 17
1
2022 - 06 - 03
1
2022 - 05 - 18
1
2022 - 05 - 16
1
2022 - 05 - 05
1
2022 - 05 - 03
1
2021 - 10 - 22
1
2021 - 10 - 04
1
2021 - 08 - 05
1
2021 - 08 - 02
1
2021 - 07 - 28
1
2021 - 05 - 06
1
Crawled Time
00:00
19
00:20
5
01:00
19
01:12
1
02:00
15
03:00
13
03:10
1
04:00
13
04:20
9
05:00
8
06:00
13
07:00
18
08:00
16
09:00
25
09:07
1
10:00
17
11:00
36
12:00
39
12:15
2
12:20
11
12:30
6
13:00
27
13:02
1
13:15
5
13:20
8
13:30
8
13:37
1
14:00
33
14:15
3
14:20
6
14:30
7
15:00
29
15:15
3
15:20
9
15:30
9
16:00
34
16:20
2
17:00
34
18:00
27
19:00
33
19:11
1
20:00
24
21:00
22
21:03
1
22:00
23
23:00
27
23:09
1
Source
www.biospace.com
16
www.globenewswire.com
4
www.prnewswire.com
19
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Astrazeneca plc
crawled time :
12:00
save search
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published:
2024-04-11
(Crawled : 12:00)
- biospace.com/
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-0.04%
|
O:
1.47%
H:
1.16%
C:
-1.27%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.38%
|
O:
3.34%
H:
0.27%
C:
-0.62%
children
approved
treatment
for
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
2.89%
|
O:
0.75%
H:
0.04%
C:
-0.1%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.46%
|
O:
-0.08%
H:
0.33%
C:
-0.53%
ARTL
|
$1.28
-1.94%
5.5K
|
Health Technology
|
-13.82%
|
O:
-4.61%
H:
4.83%
C:
3.84%
business
update
financial
results
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
Published:
2024-03-19
(Crawled : 12:00)
- biospace.com/
FUSN
|
$21.26
0.05%
0.05%
440K
|
Health Technology
|
99.81%
|
O:
96.99%
H:
1.19%
C:
1.05%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.1%
|
O:
-0.38%
H:
0.46%
C:
0.4%
astrazeneca
cancer
treat
acquire
Eplontersen granted U.S. FDA Fast Track designation for patients with transthyretin-mediated amyloid cardiomyopathy
Published:
2024-02-08
(Crawled : 12:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
2.14%
|
O:
-8.5%
H:
2.46%
C:
2.46%
IONS
|
$40.64
-0.42%
-0.42%
850K
|
Health Technology
|
-17.88%
|
O:
0.2%
H:
1.37%
C:
0.68%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.01%
|
O:
-6.81%
H:
3.02%
C:
2.42%
fda
granted
designation
eplontersen
Ionis poised for continued momentum in 2024 with product launches and key advances in robust pipeline of investigational medicines for serious diseases
Published:
2024-01-08
(Crawled : 12:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.4%
|
O:
2.71%
H:
0.36%
C:
0.11%
IONS
|
$40.64
-0.42%
-0.42%
850K
|
Health Technology
|
-19.76%
|
O:
-0.3%
H:
3.6%
C:
3.5%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.25%
|
O:
0.28%
H:
0.99%
C:
0.93%
momentum
pipeline
key
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Published:
2024-01-08
(Crawled : 12:00)
- prnewswire.com
CGEN
|
$2.03
3.57%
3.45%
450K
|
Health Technology
|
30.86%
|
O:
2.29%
H:
8.38%
C:
4.47%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.25%
|
O:
0.28%
H:
0.99%
C:
0.93%
first
million
payment
astrazeneca
cancer
trial
milestone
Compugen Reports Third Quarter 2023 Results
Published:
2023-11-07
(Crawled : 12:00)
- prnewswire.com
CGEN
|
$2.03
3.57%
3.45%
450K
|
Health Technology
|
216.21%
|
O:
-0.03%
H:
0.0%
C:
-5.83%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
7.03%
|
O:
-0.59%
H:
0.46%
C:
-0.09%
results
Pfizer Reports Third-Quarter 2023 Results
Published:
2023-10-31
(Crawled : 12:00)
- biospace.com/
HLNCF
|
$3.94
-1.48%
1.2K
|
n/a
|
1.23%
|
O:
2.0%
H:
0.5%
C:
0.5%
HLN
|
$8.22
1.11%
0.0%
3.6M
|
n/a
|
2.49%
|
O:
0.75%
H:
0.74%
C:
0.12%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
9.86%
|
O:
0.73%
H:
0.0%
C:
-1.7%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-14.89%
|
O:
-0.87%
H:
1.77%
C:
0.91%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-6.91%
|
O:
-1.65%
H:
2.78%
C:
2.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
8.91%
|
O:
0.08%
H:
0.41%
C:
0.38%
results
Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers
Published:
2023-10-12
(Crawled : 12:00)
- biospace.com/
FUSN
|
$21.26
0.05%
0.05%
440K
|
Health Technology
|
480.87%
|
O:
0.55%
H:
3.26%
C:
1.09%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.79%
|
O:
0.6%
H:
0.34%
C:
-0.45%
fpi-2068
presentation
pharmaceuticals
preclinical
therapy
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial
Published:
2023-07-27
(Crawled : 12:00)
- biospace.com/
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.16%
|
O:
0.42%
H:
0.55%
C:
-0.86%
enhertu
tumors
trial
Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027|Growing prevalence of chronic diseases to boost market growth - Technavio
Published:
2023-07-04
(Crawled : 12:00)
- prnewswire.com
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
growth
market
Revvity Announces New License Agreement for Next-Generation Base Editing Technology
Published:
2023-05-18
(Crawled : 12:00)
- biospace.com/
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-8.23%
|
O:
0.28%
H:
0.31%
C:
-0.93%
license
technology
agreement
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
Published:
2023-03-02
(Crawled : 12:00)
- globenewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
5.91%
|
O:
0.86%
H:
1.43%
C:
1.43%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.12%
|
O:
-1.43%
H:
1.34%
C:
1.28%
Pulmonary Arterial Hypertension (PAH) Drugs Global Market 2022: Sector to Reach $9.4 Billion by 2027 at a CAGR of 5.29%
Published:
2023-02-03
(Crawled : 12:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
16.9%
|
O:
0.12%
H:
0.58%
C:
0.52%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
7.18%
|
O:
-0.63%
H:
2.15%
C:
1.68%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.65%
|
O:
0.3%
H:
0.19%
C:
-0.86%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
13.15%
|
O:
0.71%
H:
0.42%
C:
-1.55%
UTHR
|
$237.99
0.45%
0.45%
400K
|
Health Technology
|
-8.31%
|
O:
-0.1%
H:
1.37%
C:
-2.48%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
8.55%
|
O:
0.79%
H:
0.69%
C:
-0.33%
global
hypertension
market
Biosimilar Therapeutic Peptides Global Market to Reach $3.5 Billion by 2026 at a CAGR of 30.3%
Published:
2022-12-06
(Crawled : 12:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
4.33%
|
O:
0.74%
H:
8.46%
C:
8.46%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
24.55%
|
O:
-1.97%
H:
0.05%
C:
0.05%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-3.44%
|
O:
-0.85%
H:
0.46%
C:
-0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.74%
|
O:
0.03%
H:
0.26%
C:
-0.27%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
2.96%
|
O:
0.33%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.19%
|
O:
-0.48%
H:
1.59%
C:
0.69%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.61%
|
O:
0.33%
H:
0.56%
C:
-0.89%
global
biosimilar
market
Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published:
2022-12-02
(Crawled : 12:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
13.8%
|
O:
1.41%
H:
0.0%
C:
-3.13%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-1.48%
|
O:
-0.61%
H:
0.08%
C:
-0.29%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
5.05%
|
O:
-1.08%
H:
1.44%
C:
1.28%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
13.47%
|
O:
-0.29%
H:
1.55%
C:
1.2%
CRNX
|
$42.98
-0.07%
-0.07%
620K
|
Health Technology
|
144.56%
|
O:
-0.57%
H:
5.9%
C:
5.44%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.31%
|
O:
-0.23%
H:
0.79%
C:
0.43%
ADAP
|
$0.97
7.97%
7.38%
1.5M
|
Health Technology
|
-51.49%
|
O:
-0.99%
H:
6.5%
C:
3.0%
research
report
therapy
cancer
market
Global Immuno-oncology Market Report to 2028: An Increase in the Research and Development in Cancer Immunotherapy Will Be Driving Growth
Published:
2022-11-28
(Crawled : 12:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
21.65%
|
O:
0.57%
H:
0.0%
C:
-2.51%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
2.21%
|
O:
-0.38%
H:
1.09%
C:
0.87%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
29.16%
|
O:
1.03%
H:
0.0%
C:
-0.68%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
7.58%
|
O:
0.29%
H:
0.45%
C:
-0.32%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
16.95%
|
O:
-0.65%
H:
0.83%
C:
-0.03%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
98.85%
|
O:
-0.49%
H:
1.67%
C:
0.64%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.6%
|
O:
0.12%
H:
0.97%
C:
-0.06%
research
global
immunotherapy
report
cancer
growth
market
Global Enzyme Inhibitor Market Report 2022-2026 & 2031: Major Companies Such as Abbott, Amgen, AstraZeneca, Bayer, & F. Hoffmann-La Roche are Focused on Strategic Partnerships to Meet Demand
Published:
2022-11-03
(Crawled : 12:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
13.5%
|
O:
-2.33%
H:
3.2%
C:
3.2%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
104.62%
|
O:
-0.25%
H:
2.48%
C:
2.15%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
9.42%
|
O:
-1.25%
H:
0.21%
C:
-0.37%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
14.82%
|
O:
-1.31%
H:
1.98%
C:
1.71%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.03%
|
O:
-0.18%
H:
0.03%
C:
-0.99%
global
companies
report
roche
market
Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research
Published:
2022-10-27
(Crawled : 12:00)
- biospace.com/
NVTA
|
$0.019
0.0%
22M
|
Health Services
|
-99.23%
|
O:
0.6%
H:
1.8%
C:
-8.62%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
18.27%
|
O:
-0.48%
H:
0.56%
C:
-0.12%
partnership
rare
research
cancer
Influenza Vaccine Market to grow by USD 2.56 Bn by 2026, Market Segmentation by Type and Geography - Technavio
Published:
2022-10-19
(Crawled : 12:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
1.14%
|
O:
-0.59%
H:
0.0%
C:
0.0%
CSLLY
|
$86.918
3.3%
60K
|
n/a
|
0.71%
|
O:
0.38%
H:
0.24%
C:
-0.31%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
23.95%
|
O:
-1.21%
H:
3.64%
C:
-0.28%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
27.2%
|
O:
0.96%
H:
0.22%
C:
-0.76%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-29.01%
|
O:
-0.36%
H:
1.95%
C:
-0.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
14.15%
|
O:
-1.37%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
22.48%
|
O:
-0.05%
H:
0.13%
C:
-2.56%
vaccine
influenza
market
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.